share_log

Takeda Pharmaceutical Shares Are Trading Lower After the Company Announced Data From the Phase 3 ADVANCE-CIDP 3 Clinical Trial.

Benzinga ·  Jun 18 22:18
Takeda Pharmaceutical Shares Are Trading Lower After the Company Announced Data From the Phase 3 ADVANCE-CIDP 3 Clinical Trial.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment